Early oncological outcomes and accuracy of risk stratification and tailoring surgical staging based on preoperative histology, Ca125 and MRI in endometrial cancer: a prospective cohort study


  • Jency Mathews Department of Surgical Oncology, Pushpagiri Medical College, Tiruvalla, Kerala, India
  • Seethal Abraham Department of Surgical Oncology, Pushpagiri Medical College, Tiruvalla, Kerala, India




Endometrial cancer, Histology, MRI and Ca-125, Outcomes, Preoperative Risk Stratification


Background: momentum to select patients who will benefit from the extensive procedures. However, the parameters used for risk stratification have variable accuracy outside of tertiary cancer centres. This study looks into the accuracy of risk stratification using preoperative histology, MRI and Ca 125 levels and the oncological outcomes after tailoring surgical staging based on the risk stratification by combining the three variables in a suburban centre with a growing cancer population.

Methods: This prospective observational cohort study was undertaken in a suburban cancer center in Pushpagiri Medical College, Tiruvalla, Kerala between June 2014 and December 2018. All patients underwent surgical staging with hysterectomy and salpingo oophorectomy as the least procedure. Lymphadenectomy was tailored according to the preoperative risk grouping and changed only in the presence of gross findings at surgery. Adjuvant treatment and follow up data obtained and collected in Microsoft Excel and analysed using statistical software SPSS version 22.

Results: Of 47 patients recruited for the study, 35 patients were available for final analysis. Preoperative histology was accurate in 73%. There was 20 % overestimation and 8% underestimation. Ca 125 levels were elevated in 15%.  MRI had an overall sensitivity of 74% and specificity of 60%. When MRI, Ca125 and histology were combined together, there was patients were deemed to be high risk. On final risk grouping, 9 patients were down staged and none were upstaged.

Conclusions: Preoperative histology, MRI and ca 125 levels have moderate accuracy individually as preoperative risk determinates. The three parameters combined together show high specificity and PPV for preoperative risk stratification and the risk stratification has not been detrimental with respect to oncological outcomes of recurrence.


India state‐level disease burden initiative cancer collaborators. The burden of cancers and their variations across the states of India: The Global Burden of Disease Study 1990-2016, The Lancet Oncol. 2018;19:10:1289-306.

Colombo N, Creutzberg C, Amant F. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Radiother Oncol. 2015;117:559-81.

Tsikouras P, Koukouli Z, Bothou A, Manav B, Iatrakis G, Zervoudis S, et al.Preoperative assessment in endometrial cancer. Is triage for lymphadenectomy possible? J BUON. 2017;22(1):34-43.

Reijnen C, Visser NC, Kasius JC. Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study. J Gynecol Oncol. 2019;30(5):e70.

Mahantshetty U, Aggarwal A, Ganesh B, Saoba S, Mulla S, Engineer R, et al. Clinical outcome of early-stage endometrioid adenocarcinoma: A tertiary cancer center experience. Int J Gynecol Cancer. 2013;23:1446-52.

Balasubramaniam G, Sushama S, Rasika B, Mahantshetty U. Hospital-based study of endometrial cancer survival in Mumbai, India. Asian Pac J Cancer Prev. 2013;14(2):977-80.

Dessai S, Adrash D, Geetha M, Arvind S, Bipin J, Nayanar S, et al. Pattern of care in operable endometrial cancer treated at a rural-based tertiary care cancer center. Indian J Cancer. 2016;53:416-9.

Lee NK, Cheung MK, Shin JY. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007;109:655-62.

Cantrell LA, Blank SV, Duska LR, Uterine carcinosarcoma: a review of the literature. Gynecol. Oncol. 2015;137:581-8.

Mendivil A, Schuler KM, Gehrig PA. Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control. 2009;16(1):46-52.

Anupama R, Kuriakose S, Vijaykumar DK. Carcinosarcoma of the uterus-a single institution retrospective analysis of the management and outcome and a brief review of literature. Indian J Surg Oncol. 2013;4(3):222-8.

Pessini SA, Zettler CG, Wender MC, Pellanda LC, Silveira GP. Survival and prognostic factors of patients treated for Stage I to Stage III endometrial carcinoma in a reference cancer center in Southern Brazil. Eur J Gynaecol Oncol. 2007;28:48-50.

DeSimone CP, Day ME, Tovar MM, Dietrich CS 3rd, Eastham ML, Modesitt SC. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol. 2006;107(6):1285-91.

Nadaf A, Rani H, Rao R, Shastri D. Pap smears in endometrial adenocarcinoma: does it have a role?. Asian Pac J Cancer Prev. 2017;18(4):1145-50.

Dijkhuizen FP, Mol BW, Brölmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89(8):1765-72.

Al-Talib A, Nezhat F, Tulandi T. The role of hysteroscopy in the diagnosis and management of endometrial cancer. Gynecol Surg. 2010;7:211-6.

Beddy P, O’Neil AC, Yamamoto AK, Addley HC, Reinhold C, Sala E. FIGO Staging system for endometrial cancer: added benefits of MR Imaging. Radio Graphics. 2012;32:241-54.

Epstein E, Blomqvist L. Imaging in endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2014;28:721-39.

Faria SC, Sagebiel T, Balachandran A, Devine C, Lal C, Bhosale PR. Imaging in endometrial carcinoma. Indian J Radiol Imaging. 2015;25:137-47.

Shrivastava S, Barmon D, Kataki AC, Deka P, Sharma JD, Choudhary BK, et al. Magnetic resonance imaging in pre-operative staging of endometrial cancer. Indian J Cancer. 2016;53:181-5.

Ortashi O, Jain S, Emannuel O, Henry R, Wood A, Evans J. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer: a prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):232-5.

Wu WJ, Yu MS, Su HY, Lin KS, Lu KL, Hwang KS. The accuracy of magnetic resonance imaging for preoperative deep myometrium assessment in endometrial cancer. Taiwan J Obstet Gynecol. 2013;52(2):210-4.

Anderson J, Shanbhag S, Cruikshank D. Use and accuracy of magnetic resonance imaging (MRI) staging of network treated endometrial cancer (EC): An audit and comparison to best evidence Sri Lanka J Obstet Gynaecol. 2009;31:104-7.

Rockall AG, Meroni R, Sohaib SA, Reynolds K, Alexander-Sefre F, Shepherd JH, et al. Evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer. 2007;17:188-96.

Luomaranta A, Bützow R, Pauna AR, Leminen A, Loukovaara M. Combined use of endometrial sample and magnetic resonance imaging in the preoperative risk-stratification of endometrial carcinomas. Acta Obstet Gynecol Scand. 2015;94(1):95-101.

Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, et al. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol. 2003;188(5):1265-72.

Mitamura T, Watari H, Todo Y, Kato T, Konno Y, Hosaka M, et al. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments. J Gynecol Oncol. 2014:PMC4195300

Lavoué V, Body N, Kerdaniel OD, Foucher F, Henno S, Cauchois A. Are preoperative histology and MRI useful for classification of endometrial cancer risk?, BMC Cancer. 201616:498:PMCID: PMC4950781.

Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, et al. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol. 2003;188(5):1265-72.

Vit W, Marketa B, Jitka H, Petra O, Petra V, Lubos M et al. A novel approach to preoperative risk stratification in endometrial cancer: the added value of immunohistochemical markers, 2019. Available at: https://doi.org/10.3389/fonc.2019.00265.

Korkmaz V, Meydanli MM, Yalçın I. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus. J Gynecol Oncol. 2017;28(6):e78.

Luomaranta A, Lohi J, Bützow R, Leminen A, Loukovaara M. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma. Int J Gynecol Cancer. 2014;24(4):697-702.

Robbins JR, Yechieli R, Laser B, Mahan M, Rasool N, Elshaikh MA. Is time to recurrence after hysterectomy predictive of survival in patients with early stage endometrial carcinoma? Gynecol Oncol. 2012;127:38-42.

Sorbe B. Juresta C, Ahlin C. Natural history of recurrences in endometrial carcinoma. Oncol Lett. 2014:PMID:PMC415626.






Original Research Articles